PD-1 and PD-L1 Expression in Indian Women with Breast Cancer.
Kishan R BharadwaKuheli DasguptaC RamachandraSuresh M C BabuAnnapoorni RangarajanRekha V KumarPublished in: European journal of breast health (2021)
These findings show that around 52% (68/132) of the TNBC cases express PD-L1 in TIICs. Hence, anti-PD-1/PD-L1 therapy alone or combined with chemotherapy may be a promising treatment for TNBC in Indian patients.